Hemodynamic Monitoring Devices Market to hit USD 2.5 billion by 2032, says Global Market Insights Inc. Selbyville, Delaware, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Hemodynamic Monitoring Devices Market size is projected to accrue USD 2.5 billion in revenue by 2032. The demand for hemodynamic monitoring...

Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in India Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin®) as a resuscitative agent

Capsule and Retia Medical Collaborate on Argos Cardiac Monitor to Streamline Device Interoperability, Protect Patient Safety ANDOVER, Mass. and VALHALLA, N.Y., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Retia Medical is the first company to utilize Capsule Technologies’ new Device Driver Interface (DDI) development strategy to...

Retia Medical Receives Purchase Orders From Three of the Top Five Hospitals in the United States VALHALLA, N.Y., Oct. 30, 2019 (GLOBE NEWSWIRE) -- Retia Medical, LLC announced today that three of the top five U.S. hospitals completed a purchase of a large number of Argos Hemodynamic Monitors....